文献速递产科母胎医学

孕11周前超声特征与早孕期母体因素预测妊娠期高血压疾病

Ultrasound features prior to 11 weeks' gestation and first-trimester maternal factors in prediction of hypertensive disorders of pregnancy.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

这项前瞻性队列研究纳入1141例单胎妊娠孕妇,在孕5+1至11+0周行超声测量,并在10-14周检测母体生化指标,评估这些指标与妊娠期高血压疾病(MHD)的关联。结果显示,最终发生MHD的孕妇体重显著更高,且滋养层体积、PAPP-A和PlGF的MoM值显著降低;结合母体身高体重及TV、FHR、PlGF的logistic回归模型预测MHD的AUC为0.80(95%CI 0.75-0.86)。

要点

  • 孕11周前滋养层体积MoM值降低与后续MHD风险相关(P=0.006)。
  • 母体体重在MHD组显著高于血压正常组(P<0.0001)。
  • 联合母体身高体重、TV、FHR及PlGF的预测模型AUC达0.80。

核心结论

  • 孕11周前联合母体身高体重、滋养层体积、胎心率及早孕期PlGF对后续MHD具有良好预测价值。

研究设计与样本

  • 前瞻性队列研究,纳入2016年2月至2018年8月在私立产科超声诊所连续就诊的单胎妊娠孕妇,孕5+1至11+0周行超声检查,共1141例纳入分析。

主要发现

  • 1086例(95.2%)分娩时血压正常,55例(4.8%)发生MHD。
  • MHD组孕妇体重显著高于血压正常组(P<0.0001)。
  • MHD组滋养层体积MoM值(P=0.006)、PAPP-A MoM值(P=0.031)和PlGF MoM值(P=0.044)显著降低。

关键数值与推荐

  • 所提出的logistic回归模型纳入母体体重和身高以及TV、FHR和PlGF的MoM值,AUC为0.80(95%CI 0.75-0.86)。

临床怎么用

  • 在孕11周前超声检查中可测量滋养层体积和胎心率,结合母体身高体重及早孕期PlGF,用于MHD风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Maternal hypertensive disorders (MHD), including pregnancy-induced hypertension and pre-eclampsia, are estimated to occur in 7-10% of pregnancies worldwide and have significant short- and long-term implications for both mother and fetus. This study aimed to determine the association of conventional and novel early first-trimester ultrasound measures with MHD and whether these ultrasound measures, combined with maternal characteristics and biochemistry, improve the prediction of MHD. METHODS: This was a prospective cohort study of consecutive women with a singleton pregnancy, attending for an early (5 + 1 to 11 + 0 weeks' gestation) ultrasound examination at a private obstetric ultrasound practice between February 2016 and August 2018. Recorded ultrasound measurements included mean sac diameter, yolk sac diameter, crown-rump length, fetal heart rate (FHR), trophoblast thickness, trophoblast volume (TV) and mean uterine artery pulsatility index. Maternal biochemistry was assessed at 10-14 weeks and included beta-human chorionic gonadotropin, pregnancy-associated plasma protein-A (PAPP-A), placental growth factor (PlGF) and maternal serum alpha-fetoprotein. Regression models were fitted for each ultrasound parameter and multiples of the median (MoM) were calculated. All measures were compared between women who had a normotensive outcome and those who subsequently developed MHD. Logistic regression analysis was used to create a prediction model for MHD based on maternal characteristics, ultrasound measurements at 5 + 1 to 11 + 0 weeks' gestation and maternal biochemistry at 10-14 weeks. RESULTS: In total, 1141 women were included in the analysis, of whom 1086 (95.2%) were normotensive at delivery and 55 (4.8%) developed MHD. Women who developed MHD weighed significantly more than did normotensive women (P < 0.0001). Mean MoM values for TV (P = 0.006), PAPP-A (P = 0.031) and PlGF (P = 0.044) were decreased significantly in pregnancies that subsequently developed MHD. The proposed logistic regression model includes maternal weight and height and MoM values for TV, FHR and PlGF, resulting in an area under the receiver-operating-characteristics curve of 0.80 (95% CI, 0.75-0.86). CONCLUSION: The combination of maternal weight and height, TV and FHR, measured prior to 11 weeks' gestation, and first-trimester PlGF appears to have good predictive value for development of MHD later in pregnancy. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hanchard TJ, de Vries BS, Quinton AE, et al. Ultrasound features prior to 11 weeks' gestation and first-trimester maternal factors in prediction of hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol. 2020. PMID: 31909523. doi:10.1002/uog.21962

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。